Cic edizioni internazionali
Functional Neurology

Add-on perampanel and aggressive behaviour in severe drug-resistant focal epilepsies

Article, 215 - 220
doi: 10.11138/FNeur/2017.32.4.215
Tag this article
Abstract
Enhanced HTML Full text PDF
This study aimed to investigate the incidence of aggressiveness in patients with severe drug-refractory focal epilepsy (DRE) who started perampanel (PER) as add-on treatment, and to identify possible predisposing factors.
Data on 49 consecutive patients with severe DRE who initiated PER were retrospectively collected. Twelve of the 49 patients experienced aggressiveness as adverse event related to PER treatment, one third of them on low (2-4 mg/day) PER dosages.
PER was discontinued in 10/12 patients because of aggressive behaviors. Aggressiveness could appear after several months or even more than one year of PER treatment. One third of patients with PER-related aggressiveness had intellectual disabilities and 5/12 patients took levetiracetam as a concomitant antiepileptic drug.
Our study suggests that the occurrence of aggressive behaviors in patients with severe DRE is not uncommon during PER treatment and that it may occur after months or even years of treatment with a stable dosage, requiring PER discontinuation in the great majority of patients.

Vol. XXXIII (No. 3) 2018 July/September

  1. Errata corrige Functional Neurology 2018;33:2 Article: Epidemiological and clinical characteristics of 492 patients in a vegetative state in 29 Italian rehabilitation units. What about outcome?
  2. Chronic stroke: an oxymoron or a challenge for rehabilitation?
    Baricich A., Carda S.
    doi: 10.11138/FNeur/2018.33.3.123
  3. Effects of a nutraceutical combination in patients with chronic lumbosacral radicular pain
    Geroin C., Tamburin S., Pagano G., Gandolfi M., Tinazzi M.
    doi: 10.11138/FNeur/2018.33.3.125
  4. Effects on balance skills and patient compliance of biofeedback training with inertial measurement units and exergaming in subacute stroke: a pilot randomized controlled trial
    Lupo A., Cinnera A.M., Pucello A., Iosa M., Coiro P., Personeni S., Gimigliano F., Iolascon G., Paolucci S., Morone G.
    doi: 10.11138/FNeur/2018.33.3.131
  5. The required coefficient of friction in Parkinson’s disease: people with freezing of gait
    Rozin Kleiner A.F., Cubillos D.M., Pinto C., Salazar A.P., Marchese R.R., Barros R.M.L., Galli M., Pagnussat A.S.
    doi: 10.11138/FNeur/2018.33.3.137
  6. Non-pharmacological interventions for agitation/aggressive behaviour in patients with dementia: a randomized controlled crossover trial
    Dimitriou T.-D., Verykouki E., Papatriantafyllou J., Konsta A., Kazis D., Tsolaki M.
    doi: 10.11138/FNeur/2018.33.3.143
  7. Improved antioxidant defense in the ventral tegmental area increases pain tolerance in male rats
    Famitafreshi H., Karimian M.
    doi: 10.11138/FNeur/2018.33.3.149
  8. Neurite orientation dispersion and density imaging can detect presymptomatic axonal degeneration in the spinal cord of ALS mice
    Gatto R.G., Mustafi S.M., Amin M.Y., Mareci T.H., Wu Y.-C., Magin R.L.
    doi: 10.11138/FNeur/2018.33.3.155
  9. An acute neurological complication of Crohn’s disease
    Battista F., Tinella E., Colosimo C.
    doi: 10.11138/FNeur/2018.33.3.165
  10. Shaping a pain-free future for cluster headache patients. The Declaration of Paris
    Rossi P., Bruce S., De Pascual M.A., Muller H., Tyminski E.K., De La Torre E.R.
    doi: 10.11138/FNeur/2018.33.3.167
Last Viewed articles: la lista degli ultimi x visitati.
  1. Add-on perampanel and aggressive behaviour in severe drug-resistant focal epilepsies
    Juhl S., Rubboli G.
    doi: 10.11138/FNeur/2017.32.4.215
credits